For example, 14-3-3σ, a downstream target gene of p53, effectively opposes and reverses cancer’s metabolic reprogramming by accelerating the degradation of MYC proto-oncogene and bHLH transcription factor (c-Myc), a protein that promotes cancer’s metabolic reprogramming. This evidence concerns the gene MYC and cancer.